NSC |
Compound |
Enrichment |
Correlation |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.012942183459279 |
0.058087731 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.012942183459279 |
0.1798084 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.012942183459279 |
0.260995 |
NSC 755442 |
Null |
0.012942183459279 |
0.081395593 |
NSC 123491 |
L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) |
0.0133012546828912 |
0.1414598 |
NSC 59620 |
(4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate |
0.0133012546828912 |
0.20701602 |
NSC 618636 |
Null |
0.0133012546828912 |
0.054323777 |
NSC 636373 |
Null |
0.0133012546828912 |
-0.077292494 |
NSC 642408 |
Null |
0.0133012546828912 |
0.047278176 |
NSC 658292 |
Null |
0.0133012546828914 |
0.16008824 |